Description

Enoxaparin Solution for Injections 10000 anti-Cha IU/ml. 0.4 ml Syringe

Ingredients

Enoxaparin solution for injections contains 10000 anti-Cha IU/ml as the active ingredient. Other ingredients may include water for injection, sodium chloride, and benzyl alcohol.

Dosage

The recommended dosage of Enoxaparin solution for injections is determined by the healthcare provider based on the patient’s condition, weight, and other factors. It is typically administered subcutaneously once or twice daily.

Indications

Enoxaparin is indicated for the prevention and treatment of deep vein thrombosis, pulmonary embolism, and to reduce the risk of blood clots in patients undergoing certain surgeries.

Contraindications

This medication is contraindicated in patients with active major bleeding, hypersensitivity to Enoxaparin, and in certain conditions like bacterial endocarditis.

Directions

Administer the injection subcutaneously into the abdomen, avoiding scars or areas with bruising. Do not rub the injection site after administration.

Scientific Evidence

Studies have shown that Enoxaparin is effective in preventing and treating blood clots. Research published in the New England Journal of Medicine demonstrated the efficacy of Enoxaparin in reducing the risk of venous thromboembolism in surgical patients.

Additional Information

It is important to monitor for signs of bleeding while on Enoxaparin therapy. Inform your healthcare provider about any unusual bleeding or bruising.

Pharmacological Effects: Enoxaparin is a low molecular weight heparin that works by inhibiting the formation of blood clots. It acts by enhancing the inhibition of factor Xa and thrombin, key players in the coagulation cascade.

Clinical Trials: Clinical trials have compared the effectiveness of Enoxaparin with other anticoagulants, showing similar efficacy with potentially fewer side effects. A study published in the Journal of Thrombosis and Haemostasis found Enoxaparin to be as effective as unfractionated heparin in preventing deep vein thrombosis.